Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
SEIZURES IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA PATIENTS
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'SEIZURES IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA PATIENTS'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Childhood Acute Lymphoblastic Leukemia
100%
Seizure
100%
Leukemia Patients
100%
Methotrexate
66%
Intrathecal Methotrexate
33%
Central Nervous System Prophylaxis
33%
High Risk
16%
Acute Lymphoblastic Leukemia
16%
Etiology
16%
Complete Remission
16%
Remission Induction
16%
Treatment Type
16%
Clinical Factors
16%
Irradiation
16%
Prophylactic Cranial Irradiation
16%
Cranial Irradiation
16%
Treatment Course
16%
Childhood Leukemia
16%
Meningeal Leukemia
16%
Intrathecal Injection
16%
Moderate Dose
16%
Seizure Risk
16%
Status Epilepticus
16%
Seizure Frequency
16%
Seizures in children
16%
Medicine and Dentistry
Epileptic Seizure
100%
Lymphoid Leukemia
100%
Methotrexate
66%
Central Nervous System
22%
Spontaneous Remission
11%
Acute Lymphoblastic Leukemia
11%
Skull Irradiation
11%
Prophylactic Cranial Irradiation
11%
Intrathecal Drug Administration
11%
Childhood Leukemia
11%
Status Epilepticus
11%
Leukemic Meningitis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Lymphatic Leukemia
100%
Intrathecal
50%
Remission
33%
Acute Lymphoblastic Leukemia
16%
Childhood Leukemia
16%
Leukemic Meningitis
16%
Epileptic State
16%